Feifei Wu
Impact in
- Neurology top 10%
- Neuroinflammation and Neurodegeneration Mechanisms
-
- Traditional Chinese Medicine Analysis
Papers in
-
- Cancer-related molecular mechanisms research 6
-
- Acute Myeloid Leukemia Research 3
- Co-authors
- Yongping Xu (3 shared papers)Huaqiang Li (3 shared papers)Shuying Li (3 shared papers)Liji Jin (3 shared papers)Jiansong You (2 shared papers)Longxuan Li (2 shared papers)Xiaoyin Lai (2 shared papers)Rongguo Hu (2 shared papers)
- Journals
- Frontiers in Pharmacology (3 papers)International Journal of Oncology (2 papers)European Journal of Medicinal Chemistry (2 papers)Scientific Reports (2 papers)Frontiers in Cell and Developmental Biology (2 papers)
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Feifei Wu
53 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 104
- Neurology 91
- Complementary and alternative medicine 90
- Cancer Research 124
- Molecular Biology 515
- Pharmaceutical Science 56
Countries citing papers authored by Feifei Wu
This map shows the geographic impact of Feifei Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifei Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifei Wu more than expected).
Fields of papers citing papers by Feifei Wu
This network shows the impact of papers produced by Feifei Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifei Wu. The network helps show where Feifei Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Feifei Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 272 | |
| 2 | 2012 | 167 | |
| 3 | 2023 | 71 | |
| 4 | 2024 | 55 | |
| 5 | 2017 | 50 | |
| 6 | 2021 | 49 | |
| 7 | 2013 | 47 | |
| 8 | 2015 | 47 | |
| 9 | 2016 | 44 | |
| 10 | 2016 | 42 | |
| 11 | 2016 | 40 | |
| 12 | 2020 | 39 | |
| 13 | 2021 | 32 | |
| 14 | 2022 | 31 | |
| 15 | 2015 | 30 | |
| 16 | 2014 | 29 | |
| 17 | 2020 | 27 | |
| 18 | 2018 | 26 | |
| 19 | 2024 | 24 | |
| 20 | 2021 | 22 |
About Feifei Wu
Feifei Wu is a scholar working on Cancer Research, Hematology, Molecular Biology, Physiology and Pharmaceutical Science, having authored 57 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (6 papers), Pain Mechanisms and Treatments (4 papers), Acute Lymphoblastic Leukemia research (4 papers), Plant-Microbe Interactions and Immunity (3 papers), Acute Myeloid Leukemia Research (3 papers), Plant Stress Responses and Tolerance (3 papers), Synthesis and Characterization of Heterocyclic Compounds (3 papers) and Mitochondrial Function and Pathology (3 papers). The work is most often cited by research in Neurology (91 citations), Complementary and alternative medicine (90 citations), Cancer Research (124 citations), Molecular Biology (515 citations) and Pharmaceutical Science (56 citations). Feifei Wu has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Yongping Xu, Huaqiang Li, Shuying Li, Liji Jin, Jiansong You, Longxuan Li, Xiaoyin Lai, Rongguo Hu, Limin Xu and Yufeng Jiang. Their work appears in journals such as Frontiers in Pharmacology, International Journal of Oncology, European Journal of Medicinal Chemistry, Scientific Reports and Frontiers in Cell and Developmental Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.